[研究报告] 免疫组织化学市场预计将从 2021 年的 21.7161 亿美元增至 2028 年的 35.8531 亿美元;预计 2021 年至 2028 年的复合年增长率为 7.4%。
市场洞察和分析师观点:
免疫组织化学 (IHC) 是一种基于显微镜的技术,用于观察组织样本中的细胞成分(例如蛋白质或其他大分子)。它是医疗保健和病理学中常用的工具。IHC 广泛应用于研究应用,其中分析感兴趣的分子以研究它们在细胞、分子或组织水平上在健康和患病细胞和组织中的作用。有许多 IHC 方法可用于定位抗原。IHC 主要考虑标本类型和检测灵敏度等参数。全球免疫组织化学 ihc 市场规模预计将从 2021 年的 217.161 亿美元增至 2028 年的 35.8531 亿美元。预计 2021 年至 2028 年市场将以 7.4% 的复合年增长率增长。
增长动力和挑战:
慢性病和传染病发病率上升
免疫组织化学 (IHC) 是一种重要的应用,即单克隆和多克隆抗体用于组织测定和特定疾病抗原的分布。它主要用于检测多种传染病,如登革热、肝炎、人类免疫缺陷病毒 (HIV)。肥胖、癌症、糖尿病、心脏病和中风等慢性疾病也被认为是免疫组织化学的主要应用,有助于诊断这些疾病。
根据联合国艾滋病规划署 (UNAIDS) 的数据,2020 年全球约有 3760 万人感染艾滋病毒。其中,3590 万为成年人,170 万为儿童(<15 岁)。据估计,2020 年全球有 150 万人感染艾滋病毒。根据艾滋病毒和艾滋病组织 (AVERT) 的数据,2018 年,美国有 110 万居民感染了艾滋病毒,而亚太地区有 520 万艾滋病毒感染者。根据欧洲疾病预防控制中心的数据,2018 年欧洲约有 200 万人感染了艾滋病毒。
糖尿病在全球老年人口中发病率很高。超重和肥胖人群患糖尿病的几率更高。根据美国疾病控制和预防中心 (CDC) 2017 年公布的数据,美国约有 3030 万人患有糖尿病,占美国人口的 94%。其中约有 2310 万人被诊断患有糖尿病,而约有 720 万人没有接受适当的诊断程序。
全球发达经济体和发展中经济体的肥胖率都在迅速上升。不健康的生活方式和久坐不动的生活是肥胖人数增加的主要原因。根据美国国家卫生统计中心 (NCHS) 发布的数据显示,2015 年至 2016 年间,美国肥胖患病率预计约为 39.8%,约有 9330 万美国成年人患有肥胖症。中年人肥胖发病率 (42.7%) 明显高于年轻人 (35.7%)。美国肥胖人数的增加也导致医疗支出增加。
心血管疾病(CVD)包括脑血管病、风湿性心脏病、冠心病等,是全球发病率和死亡率最高的疾病。根据2017年欧洲心血管疾病统计数据,心血管疾病每年导致390万人死亡,欧盟死亡人数超过180万人。心血管疾病在欧洲占所有死亡人数的45.0%,在欧盟占死亡人数的37.0%。此外,根据美国心脏协会(AHA)2019年的统计数据,美国有1.215亿成年人患有心血管疾病,约占美国成年人口的一半。
此外,全球癌症发病率和死亡率不断上升,癌症已成为人类死亡的首要原因。根据世界卫生组织 2018 年的数据,全球约有 960 万人死于癌症。
此外,美国国家癌症研究所预测,2018年美国将诊断出约1,735,350例新癌症病例。同样,在中国,根据世界卫生组织公布的数据,2018年发现约430万例新癌症病例,并记录了290万例癌症死亡病例。慢性病和传染病发病率的增加预计将在世界范围内产生对免疫测定测试的需求。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场限制
免疫组织化学的局限性
免疫组织化学利用抗体的特异性来检测组织或细胞中的靶分子。此外,IHC 也已被证明是毒理学研究的一项强大技术。然而,与该技术的特异性和准确性相关的一些限制将其采用限制在一定水平。
试剂缺乏特异性是一个比普遍认识到的更常见的问题。缺乏特异性可能导致资源和时间的巨大浪费。此外,该技术的应用也受到抗体的物理限制的限制。此外,如果染色研究设计没有经过仔细的构思和控制,免疫组织化学可能会产生误导。
虽然该系统是检测给定标记表达的最简单、最方便的方法,但由于灵敏度不足、需要每种一抗单独与荧光团或酶结合以及染色问题等限制,它在临床和研究应用中并未得到有效应用。因此,与 IHC 技术相关的限制可能会在一定程度上阻碍市场增长。
报告细分和范围:
“全球免疫组织化学市场”根据应用、产品、最终用户和地理位置进行细分。基于产品的全球免疫组织化学市场已细分为抗体、设备、试剂和试剂盒。基于应用的全球免疫组织化学市场细分为诊断和药物测试。2021 年,诊断部门可能会占据最大的市场份额。基于最终用户的全球免疫组织化学市场细分为医院和诊断实验室、研究机构等。基于地理位置的免疫组织化学市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)
节段分析:
根据产品,已细分为抗体、设备、试剂和试剂盒。抗体部分很可能在 2021 年占据最大的市场份额。此外,由于试剂的现有使用、高容量消耗和产品创新,预计在预测期内试剂部分将在市场上实现最高的复合年增长率。试剂使研究人员能够以卓越的水平对组织和测定进行深入分析。免疫组织化学中常用的试剂包括组织染色剂、阻断和固定试剂、显色底物、稳定剂、溶剂和蛋白水解酶等。赛默飞世尔科技公司、Abcam plc.、Enzo Life Sciences, Inc.、QIAGEN、Bio-Rad Laboratories 是该领域的主要参与者。新型试剂还能提高数据数量和质量的精确度和准确性,并提供出色的服务效果。试剂的现有使用、不断增长的研发支出、不断增加的政府支持和技术创新是预计在预测期内加强试剂部门增长的因素之一。
根据应用,全球免疫组织化学市场分为诊断和药物检测。2021 年,诊断部分可能会占据最大的市场份额。此外,由于全球各种医疗状况的检测和诊断增加,预计该部分的需求在 2021 年至 2028 年期间也将以最快的复合年增长率增长。通过免疫组织化学诊断各种慢性疾病,如癌症、自身免疫性疾病、传染病和肾病等,已经变得非常有效。使用抗体、试剂、染料和其他分子诊断工具可以快速、在更短的时间内获得重要信息。
免疫组织化学的使用可以准确解释诊断,并为临床医生提供最佳治疗方法。免疫组织化学的其他优势包括识别疾病的遗传和分子原因,这可能有助于提供最佳治疗方法和患者护理。它还有助于治疗应用,使人们能够根据免疫学结果评估治疗技术。
此外,免疫组织化学技术比其他医学诊断更具成本效益。与医学诊断相比,免疫组织化学诊断仅需几百美元。此外,技术进步使得抗体和分子诊断工具易于获得。因此,由于免疫组织化学在疾病诊断方面的优势,估计市场在预测期内可能会呈指数级增长。全球免疫组织化学市场基于最终用户细分为医院和诊断实验室、研究机构等。2021 年,医院和诊断实验室部门可能占据最终用户最大的市场份额。此外,由于传染病、癌症和自身免疫性疾病患病率上升,该部门预计在未来几年也将以最快的速度增长。这些疾病病例的增加预计将推动对其诊断的需求,从而导致该部门的增长。医院是任何国家医疗保健系统的重要组成部分之一。技术进步有助于医院诊断和治疗各种疾病,如心脏病、神经病、艾滋病毒、肝炎、肿瘤等。医院为患有各种疾病和病症的患者提供广泛的医疗保健和医疗服务。如今,医院为患者提供更好的服务。通常,此类医院提供多种适应症的诊断和治疗服务。大量患者入院接受手术,而一些患者则走进来接受诊断治疗。在入院患者中,大多数患者已经患有某些疾病。因此,为了实时监测和控制他们的健康状况,大多数医院都设有临床诊断实验室。因此,医院为免疫组织化学市场贡献了相当大的市场份额,预计在预测期内将继续保持这一趋势。
诊断中心提供组织、细胞和体液的完整分析,提供全面的诊断,以确保为患者提供最高质量的服务和护理。诊断中心拥有现代化的诊断和病理设备和仪器,如生化分析仪、血液学分析仪、诊断试剂盒、PCR、凝胶电泳等。病理学和诊断中心允许患者在几小时到几天内从现场病理学家那里得到一份详细的报告。例如,成立于 1978 年的美国实验室控股公司是提供全方位病理学和诊断服务的领先诊断实验室之一。LabCorp 以高质量和富有同情心的患者护理赢得了独特的声誉。病理学技术的进步在短时间内提供快速准确的结果,可能会推动病理学和诊断中心部门在预测年份的增长。
免疫组织化学市场分析、区域分析:
根据地理位置,免疫组织化学市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美是免疫组织化学最大的市场,美国、加拿大和墨西哥是该地区市场的主要贡献者。北美市场的增长特点是癌症患病率不断上升,癌症诊断工具也相应增长,免疫组织化学技术不断进步,老年人口不断增加。此外,医疗保健支出不断增长可能是北美免疫组织化学市场增长的主要刺激因素。
行业发展和未来机遇:
以下列出了全球免疫组织化学市场的主要参与者采取的各种举措:
- 2021 年 7 月,安捷伦科技公司的 PD-L1 IHC 22C3 pharmDx 扩大了非小细胞肺癌 (NSCLC) 的 CE-IVD 标志。它被标记为可在欧盟 NSCLC 患者中长期使用。它现在可用于识别肿瘤 PD-L1 表达为肿瘤比例评分 (TPS) 50% 的 NSCLC 患者,以便使用 Libtayo (cemiplimab) 进行治疗。
- 2020 年 4 月,Bio-Rad 推出了一款基于血液的免疫测定试剂盒,用于检测 Covid-19。这是一种基于血液的免疫测定试剂盒,用于识别导致 Covid-19 的病毒 SARS-CoV-2 的抗体。
- 2020 年 9 月,赛默飞世尔和 Humanigen 同意扩大 COVID-19 单克隆抗体的生产规模。这项交易预计将帮助扩大这家加州生物技术公司的 lenlizumab 的生产规模,lenlizumab 是细胞因子风暴的临床阶段候选药物,该公司正在对严重的 COVID-19 患者进行测试,以期在今年之后获得紧急使用批准。
免疫组织化学市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响免疫组织化学市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的免疫组织化学市场细分和地理位置。
- 获取免疫组织化学市场的区域特定数据
免疫组织化学市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 21.7亿美元 |
2028 年市场规模 | 35.9亿美元 |
全球复合年增长率(2021 - 2028) | 7.4% |
史料 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按应用
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
免疫组织化学市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在免疫组织化学市场运营的主要公司有:
- F. Hoffmann-LA 罗氏公司
- 默克公司
- 珀金埃尔默公司
- 赛默飞世尔科技公司
- 艾博抗公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解免疫组织化学市场顶级关键参与者概况
Covid-19的影响:
北美爆发的 COVID-19 疫情对美国产生了重大影响。该国的检测呈阳性的患者人数最多。全国各地的各种医疗研究中心都专注于 COVID 19 治疗。由于封锁、旅行禁令和企业关闭,COVID-19 已影响到各国的经济和行业。COVID-19 危机使许多国家的公共卫生系统不堪重负,并凸显了对卫生系统进行可持续投资的强烈需求。随着 COVID-19 疫情的进展,预计医疗保健行业的增长将出现下降。由于对体外诊断产品的需求增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,预计医疗保健专业人员的虚拟咨询将成为疫情后主流的医疗服务模式。随着远程医疗改变医疗服务,数字医疗将在未来几年继续蓬勃发展。此外,临床试验中断以及随后药物上市的延迟也有望为未来完全虚拟试验铺平道路。mRNA 等新技术预计将出现并改变制药行业,预计未来几年市场也将见证更多的垂直整合和合资企业。
竞争格局和重点公司:
全球免疫组织化学市场的一些知名参与者包括 F. Hoffmann-LA Roche AG、Merck KGaA、PerkinElmer, Inc.、Thermo Fisher Scientific, Inc.、Abcam Plc、Agilent Technologies、Bio SB、Bio-Rad Laboratories、Cell Signaling Technology, Inc. 和 Danaher Corporation 等。这些公司专注于新产品的推出和地域扩张,以满足全球日益增长的消费者需求,并增加其专业产品组合的产品范围。它们在全球拥有广泛的业务,这使它们能够服务于大量客户,从而增加其市场份额。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Pipe Relining Market
- Smart Grid Sensors Market
- Precast Concrete Market
- Surgical Gowns Market
- Constipation Treatment Market
- Emergency Department Information System (EDIS) Market
- Military Rubber Tracks Market
- Artificial Intelligence in Defense Market
- Virtual Event Software Market
- Artificial Intelligence in Healthcare Diagnosis Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asia-Pacific is the lucrative for the immunohistochemistry market.
Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.
Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.
Development opportunities in emerging countries are likely to fuel the market growth in the comping years.
Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.
Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.
Antibodies is the most influencing segment growing in the immunohistochemistry market.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Immunohistochemistry Market
- F. Hoffmann-LA Roche AG
- Merck KGaA
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Agilent Technologies
- Bio SB
- Bio-Rad Laboratories
- Cell Signaling Technology, Inc.
- Danaher Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.